The NRG Oncology Podcast

The NRG Oncology Podcast, developed by NRG Oncology, is hosted by Drs. Stephen Chun and Lauren Henke. Stephen and Lauren delve into a variety of topics impacting the oncology community via interviews with various stakeholders throughout the NRG Oncology organization.

The NRG Oncology Podcast is a health podcast hosted by NRG Oncology, with 48 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

NRG Oncology hosts The NRG Oncology Podcast, a health show with 48 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  The NRG Oncology Podcast

  NRG-HN016: The "CONCISE" Study for Locoregionally Advanced Head and Neck Cancer Patients that are Unable to Take Cisplatin

  Aug 13, 202617 min

  Our co-hosts interview the PI of the active NRG-HN016 (CONCISE) trial, Dr. Loren Mell. The CONCISE study is a randomized phase III trial comparing radiation therapy (RT) plus carboplatin/paclitaxel vs. RT plus cetuximab for patients with locoregionally advanced head and neck cancer who have a contraindication to cisplatin. CONCISE is the first trial comparing the two most commonly used regimens for this population, and the first “pragmatic” trial for solid tumors to be conducted by NRG Oncology.

  ListenShow Notes
• 

  The NRG Oncology Podcast

  NRG-GU015, the "ARCHER" Study for Muscle Invasive Bladder Cancer

  Jul 30, 202628 min

  Our co-hosts welcome Dr. Scott Delacroix and Dr. Himanshu Nagar to discuss bladder cancer, bladder preservation, and the newly activated NRG-GU015 (ARCHER) clinical trial. In this episode, the experts explore who may benefit from bladder-sparing chemoradiation, dispel common misconceptions about organ preservation, and explain how GU015 is evaluating a shorter, adaptive radiation treatment approach that could make curative therapy more accessible for patients with muscle-invasive bladder cancer. They also discuss the importance of multidisciplinary care, patient-centered decision-making, and how innovations in radiation therapy and systemic treatments are shaping the future of bladder cancer care. Whether you're a clinician, researcher, or simply interested in advances in oncology, this episode offers valuable insights into a trial designed to improve both outcomes and quality of life for patients.

  ListenShow Notes
• 

  The NRG Oncology Podcast

  NRG2026 and Glioblastoma Awareness Day Special

  Jul 15, 202639 min

  For Glioblastoma Awareness Day we discuss the NRG-CC017 study of TMPRT + Temozolomide for glioblastoma with PI, Dr. Huang. We also discuss the challenges faced by larger institutions with Dr. Abraham.

  ListenShow Notes
• 

  The NRG Oncology Podcast

  Uterine Cancer Awareness Month 2026

  Jun 23, 202650 min

  This special Uterine Cancer Month episode includes three different perspectives in Uterine Cancer research. First we interview uterine and ovarian cancer survivor, NRG PAC Member, and Uterine Corpus Subcommittee Patient Advocate, Anna Wilson. Second we look at the recently activated NRG-GY035 clinical study with PI Dr. Amanda Fader. Lastly we discuss uterine cancer research within NRG with Gynecologic Cancer Committee Chair, Dr. Carol Aghajanian.

  ListenShow Notes
• 

  The NRG Oncology Podcast

  Prostate Cancer Analysis and Translational Science from ASCO 2026

  May 30, 202630 minS0

  <p>In this episode, we discuss the results of the combined analysis of the prostate cancer studies RTOG 9202, 9413, 9902, and 0521 as well as learn more about translational science at NRG. </p>

  ListenShow Notes

Recent guests on The NRG Oncology Podcast. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.